THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 52 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,913,879 | -71.2% | 711,479 | 0.0% | 1.76% | -52.7% |
| Q2 2023 | $6,638,099 | +5.1% | 711,479 | 0.0% | 3.72% | -9.8% |
| Q1 2023 | $6,317,934 | +78.3% | 711,479 | 0.0% | 4.12% | +245.1% |
| Q4 2022 | $3,543,165 | -14.1% | 711,479 | 0.0% | 1.19% | -21.0% |
| Q3 2022 | $4,127,000 | +4.9% | 711,479 | 0.0% | 1.51% | +20.3% |
| Q2 2022 | $3,934,000 | -52.0% | 711,479 | 0.0% | 1.26% | -25.2% |
| Q1 2022 | $8,203,000 | -9.1% | 711,479 | 0.0% | 1.68% | +31.6% |
| Q4 2021 | $9,022,000 | – | 711,479 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 3,212,732 | $40,737,000 | 10.01% |
| Lynx1 Capital Management LP | 409,358 | $5,191,000 | 4.53% |
| Foresite Capital Opportunity Management V, LLC | 468,820 | $5,945,000 | 3.99% |
| Orbimed Advisors | 16,838,668 | $213,514,000 | 2.74% |
| Nextech Invest Ltd. | 611,310 | $7,751,000 | 2.04% |
| Omega Fund Management, LLC | 711,479 | $9,022,000 | 1.28% |
| Boxer Capital, LLC | 892,057 | $11,311,000 | 0.44% |
| DAFNA Capital Management LLC | 97,500 | $1,236,000 | 0.31% |
| Rock Springs Capital Management LP | 437,329 | $5,545,000 | 0.13% |
| Woodline Partners LP | 250,000 | $3,170,000 | 0.04% |